Related Experiment Video
Updated: May 6, 2026

06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
24.2K
Refractory Renovascular Hypertension from Paraganglioma: A Case Report
Ayako Shimizu1, Kota Kakeshita1, Teruhiko Imamura1
1Second Department of Internal Medicine, University of Toyama, Toyama, Japan.
The American Journal of Case Reports
|October 22, 2025
Summary
A rare case of secondary hypertension caused by paraganglioma compressing the renal artery is presented. Successful treatment involved angioplasty, aneurysm embolization, and tumor resection, leading to long-term normotension.
Area of Science:
- Endocrinology
- Nephrology
- Vascular Surgery
Background:
- Secondary hypertension diagnosis and management can be challenging.
- Renovascular hypertension and catecholamine-secreting tumors (pheochromocytomas, paragangliomas) are known causes.
- The rare co-occurrence of these conditions requires careful consideration.
Purpose of the Study:
- To report a unique case of a young woman with recurrent renovascular hypertension.
- To highlight the diagnostic challenge posed by a paraganglioma as the underlying cause.
- To describe a successful multi-modal treatment strategy.
Main Methods:
- A young woman presented with recurrent hyper-reninemic hypertension post-renal artery stenosis angioplasty.
- Investigation revealed an ipsilateral renal artery aneurysm and a compressing paraganglioma.
- Treatment included repeat angioplasty, aneurysm coil embolization, and paraganglioma resection.
Main Results:
- The patient achieved sustained normotension for 6 years post-intervention without antihypertensive medication.
- Initial improvement after angioplasty suggested renal artery stenosis as a primary driver.
- The paraganglioma was identified as the ultimate underlying cause.
Conclusions:
- Paraganglioma should be considered in cases of persistent or recurrent renovascular hypertension.
- A strategic approach combining angioplasty, embolization, and surgical resection is effective.
- This case underscores the importance of identifying rare underlying causes for complex hypertension.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
2.1K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Aortic Regurgitation I: Introduction
1.6K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.6K
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598

